JSPR
Jasper Therapeutics Inc
0.6341$
+9.1%
vs. previous close
Closing price · As of: Sep 17, 2026
Filings
Filings
Listed US companies must report material events to the Securities and Exchange Commission. This page lists the filings of Jasper Therapeutics Inc (JSPR) with date, type and a link to the original document.
| Date | Type | Filing | Original |
|---|---|---|---|
| 08/26/2026 | Current report (8-K) | Jasper Therapeutics, Inc. (JSPR): Entry into a Material Definitive Agreement | View report ↗ |
| 08/17/2026 | Ownership disclosure | Form SC 13G filed with the SEC | View document ↗ |
| 08/14/2026 | Current report (8-K) | Jasper Therapeutics, Inc. (JSPR): Results of Operations and Financial Condition; Financial Statements and Exhibits | View report ↗ |
| 08/03/2026 | Current report (8-K) | Jasper Therapeutics, Inc. (JSPR): Submission of Matters to a Vote of Security Holders | View report ↗ |
| 07/31/2026 | Current report (8-K) | Jasper Therapeutics, Inc. (JSPR): Other Events | View report ↗ |
| 07/17/2026 | Current report (8-K) | Jasper Therapeutics, Inc. (JSPR): Entry into a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets; Unregistered Sales of Equity Securities; Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; Regulation FD Disclosure; Financial Statements and Exhibits | View report ↗ |
| 07/16/2026 | Current report (8-K) | Jasper Therapeutics, Inc. (JSPR): Regulation FD Disclosure; Financial Statements and Exhibits | View report ↗ |
Showing the 100 most recent filings of the selected type.
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Filings: SEC EDGAR
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.